With sales of its respiratory drugs doing well, GlaxoSmithKline has been spending hundreds of millions of dollars to expand manufacturing of several kinds of inhalers. But a glitch at one of its ...

GlaxoSmithKline has added three more lots of its Ventolin inhalers to its recent recall, bringing the total to more than 1.1 million units. According to a recent FDA Enforcement Report, the drugmaker ...

Hundreds of thousands of Facebook users in February 2018 shared an article warning that the pharmaceutical company GlaxoSmithKline had issued a massive recall of Ventolin inhalers, an essential ...

The transition from CFC to HFA propellants is occurring because of public health concerns about the detrimental effects of CFCs on stratospheric ozone levels. In 2005, the Food and Drug Administration ...

Reviewers examine the consequences of switching to hydrofluoroalkane, which is replacing chlorofluorocarbon, or CFC, as a key ingredient in albuterol inhalers designed to relieve asthma. The FDA has ...

MONTGOMERY CO., AL (WSFA) - Do you or your children rely on an EpiPen or inhaler to combat allergies and asthma? Two separate recalls on two common medications have parents on high alert and doctors ...

A nationwide shortage of the asthma medication albuterol has been ongoing since last fall and experts fear it's only expected to get worse. Albuterol can be taken in several forms but it's the ...

WASHINGTON (Reuters) - U.S. patients who use certain asthma inhalers made with ozone-depleting propellants should talk to their doctors now about alternatives ahead of a ban that starts in January, ...

In March 2005, the US Food and Drug Administration announced that albuterol inhalers using CFC propellants should no longer be produced, marketed, or sold in the United States after December 31, 2008.

Asthma UK said that "faulty inhalers could put people's lives at risk" as it called on patients to check whether their inhaler needed to be returned. The call comes after the Medicines and Healthcare ...

INDIANAPOLIS (WTHR) — The FDA has approved the first generic Albuterol inhaler, which could save lives and money for the 26 million Americans suffering from asthma. ProAir HFA — better known as ...